Rhenovia Pharma Language Contact
Search
   
    HomeCompanyScience & TechnologyServices & ProductsInvestors & MarketNews & EventsContact Us    
    Rhenovia Pharma    
   
RSS

Stay connected & subscribe to Rhenovia News Feed

Get English News Feed
Home > Services & Products

Services & Products

Rheddos System™: Drug Discovery Optimization Service

Principle: integrate biosimulation The service that Rhenovia proposes to pharma and biotech companies is an interactive partnership to evaluate their drug discovery process by analyzing drug's effects on integrated biological systems and by searching synergistic drug / mechanism combinations. Thus, Rhenovia proposes to...

> learn more

Case study

Example of a contract signed with a pharma partner Based on Rhenovia's claims that A - Combining a drug candidate with another appropriate compound may result in synergistic increase of efficacy B- Showing improved efficacy of such a drug candidate can provide competitive advantage the client which has in PhII clinical development 25 drug candidates with various modes of action asks to identify paired combinations of these compounds that result in synergistic pharmacological effects.

> learn more

First Operational Service

Memory platform for cognitive deficits and glutamate/GABA imbalance The first operational service offered to pharma and biotech partners is directed towards drug candidates and mechanisms involved in learning and memory...

> learn more

Procedure and Method

The way Rhenovia proposes to put in place a service with a pharma or biotech client involves two main steps...

> learn more

Work with us

Rhenovia's goal is to tailor its service and adapt its technology platforms to specific needs of pharma and biotech partners. Starting from generic platforms, Rhenovia can modify the level complexity at synaptic, to neuronal or network levels. Platforms can also be extended to other NS functions and pathologies, neuronal circuits, or functional read-outs....

> learn more

Consulting Service

We offer consulting services in the field of life sciences with special emphasis on health issues.

> learn more
 
News

News & Events

Sep 2010 - Performing drug testing on the computer instead in bench experiment: Rhenovia presents a new tool of biosimulation at BioPharm America, 15-17 September 2010, Boston.

Aug 2010 - DID RHENOVIA UNRAVEL THE CAUSE OF ONE OF THE MAJOR SETBACKS OF THE PHARMACEUTICAL INDUSTRY? The Rhenovia team used its modeling and biosimulation platform to explain the failures of NMDA receptor antagonists in stroke.

Press Releases

Oct 2009 - Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA

Sep 2009 - 26 September 2009 - Rhenovia participates at the French economical mission in Seoul and Tokyo on October 3-9, 2009.

Publications

Computational studies of NMDA receptors: differential effects of neuronal activity on efficacy of competitive and noncompetitive antagonists

Brain-computer interfaces ( An international assessment of research and development trends) Auteur(s) : BERGER T.W, MCFARLAND D.J., TAYLOR D.M Date de parution: 09-2008 Langue : ANGLAIS

Newsletters

Rhenovia Receives €2.5M to Further Develop Its Biosimulation Platform GEN News Highlights

Newsletter April 2008

    
    © 2010 Rhenovia Pharma - Limited. All Rights Reserved. Use of this website is governed by our Terms of Use.